Mulligan v. GlaxoSmithKline LLC et al
| JANET MULLIGAN |
| GlaxoSmithKline LLC, Pfizer Inc., Boehringer Ingelheim Pharmaceuticals, Inc., Sanofi U.S. Services Inc. and Chattem, Inc. |
| 4:2021cv10089 |
| August 27, 2021 |
| US District Court for the Southern District of Florida |
| Tort Product Liability |
| 28 U.S.C. ยง 1332 |
| Plaintiff |
Docket Report
RSS Track this Docket
This docket was last retrieved on August 27, 2021. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 1 COMPLAINT against All Defendants. Filing fees $ 402.00 receipt number AFLSDC-14965941, filed by JANET MULLIGAN. (Attachments: #1 Civil Cover Sheet)(LoPalo, Christopher) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Florida Southern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
